US Stock MarketDetailed Quotes

RGC Regencell Bioscience

Watchlist

5.460
-0.010-0.18%

Close May 22 16:00 ET

71.05MMarket Cap-12133P/E (TTM)

Regencell Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

(FY)Jun 30, 2019

(FY)Dec 31, 2017

(Q4)Dec 31, 2017

(Q3)Sep 30, 2017

(Q2)Jun 30, 2017

(Q1)Mar 31, 2017

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

5.77%-4.96M

-586.43%-5.27M

-5.61%-767.31K

-85.83%-726.57K

-390.99K

Net income from continuing operations

20.18%-6.06M

-463.92%-7.59M

-65.78%-1.35M

-107.77%-812.37K

---390.99K

-34.13%112.3M

-46.38%28.9M

-73.05%11.4M

-29.76%23.6M

18.92%48.4M

Operating gains losses

--1.42K

----

66.32%-6.4M

75.00%-1.1M

-100.00%-16.8M

69.00%-3.1M

284.21%14.6M

Depreciation and amortization

27.35%769.69K

2,184.54%604.4K

178.02%26.46K

--9.52K

--0

8.24%249.7M

6.54%63.5M

6.67%62.4M

10.54%62.9M

9.34%60.9M

Deferred tax

----

-125.00%-600K

-98.11%100K

311.76%7M

-700.00%-3.2M

-7.14%-4.5M

Other non cash items

-695.68%-85.4K

---10.73K

----

4.38%14.3M

5.88%3.6M

2.70%3.8M

0.00%3.5M

9.68%3.4M

Change In working capital

50.30%-508.95K

-285.19%-1.02M

624.91%552.98K

--76.28K

--0

31.16%-46.4M

85.23%32.6M

67.67%-32.3M

-220.35%-148M

65.79%101.3M

-Change in receivables

----

---27.7M

---111.3M

107.55%22M

-341.86%-38M

-9.29%99.6M

-Change in inventory

----

-186.67%-1.3M

325.00%900K

-70.00%600K

-300.00%-400K

-700.00%-2.4M

-Change in prepaid assets

77.88%-23.15K

-1,237.23%-104.63K

58.20%-7.82K

---18.72K

--0

-44.00%-3.6M

-28.33%4.3M

4,300.00%4.2M

-252.38%-7.4M

25.40%-4.7M

-Change in payables and accrued expense

100.38%1.87K

-187.20%-489.03K

490.32%560.8K

--95K

--0

115.65%6.7M

16.45%106.2M

70.31%-21.2M

-2,203.03%-76M

96.12%-2.3M

-Change in other current liabilities

-13.30%-487.67K

---430.42K

--0

----

-Change in other working capital

----

13.14%-20.5M

-0.31%32.5M

7.56%-37.9M

19.14%-26.2M

-35.47%11.1M

Cash from discontinued investing activities

Operating cash flow

5.77%-4.96M

-586.43%-5.27M

-5.61%-767.31K

-85.83%-726.57K

---390.99K

-0.15%409.9M

-5.10%154.3M

425.27%47.8M

-172.07%-41.8M

38.05%249.6M

Investing cash flow

Cash flow from continuing investing activities

100.55%58.98K

-10.78M

-117.84K

Capital expenditure reported

----

-16.52%-250.4M

-25.25%-74.9M

-8.37%-71.2M

-2.23%-59.6M

-43.73%-44.7M

Net PPE purchase and sale

96.62%-26.42K

---780.88K

--0

---117.84K

--0

----

Net business purchase and sale

----

-1,164.23%-173.2M

290.00%9.5M

90.00%-400K

-4,415.00%-180.6M

-142.86%-1.7M

Net investment purchase and sale

100.85%85.4K

---10M

--0

----

--10.3M

--0

Net other investing changes

----

828.57%13M

-7,400.00%-7.3M

--8.5M

--0

15.38%1.5M

Cash from discontinued investing activities

Investing cash flow

100.55%58.98K

---10.78M

--0

---117.84K

--0

-83.63%-410.6M

-12.36%-72.7M

24.25%-52.8M

-285.55%-240.2M

-66.91%-44.9M

Financing cash flow

Cash flow from continuing financing activities

-99.40%134.91K

4,995.12%22.41M

-55.50%439.75K

105.43%988.08K

480.99K

Net issuance payments of debt

--0

-170.58%-431.97K

-38.06%612.06K

105.43%988.08K

--480.99K

682.95%126.5M

-65.96%-7.8M

8.57%-6.4M

4,829.03%146.6M

14.49%-5.9M

Net common stock issuance

--0

--22.67M

--0

----

Cash dividends paid

----

0.00%-138.9M

0.00%-34.5M

-0.29%-34.6M

0.00%-34.5M

0.28%-35.3M

Net other financing activities

-17.74%134.91K

195.18%164K

---172.31K

----

-866.67%-4.6M

--0

-270.00%-3.4M

62.50%-1.2M

Cash from discontinued financing activities

Financing cash flow

-99.40%134.91K

4,995.12%22.41M

-55.50%439.75K

105.43%988.08K

--480.99K

89.38%-17M

-10.44%-42.3M

-0.99%-41M

405.34%108.7M

6.81%-42.4M

Net cash flow

Beginning cash position

10,700.66%6.42M

-84.65%59.41K

59.05%386.98K

58.71%243.31K

--153.3K

12.25%246.5M

1.39%189.5M

-18.26%235.5M

24.63%408.8M

12.25%246.5M

Current changes in cash

-175.01%-4.77M

2,040.86%6.36M

-328.00%-327.57K

59.63%143.67K

--90K

-165.80%-17.7M

-34.06%39.3M

54.55%-46M

-334.34%-173.3M

49.72%162.3M

Effect of exchange rate changes

---83.15K

--0

----

End cash Position

-75.61%1.56M

10,700.66%6.42M

-84.65%59.41K

59.05%386.98K

--243.31K

-7.18%228.8M

1.39%189.5M

-18.26%235.5M

24.63%408.8M

Free cash flow

17.49%-4.99M

-688.20%-6.05M

9.13%-767.31K

-115.97%-844.41K

---390.99K

-18.46%159.5M

-22.76%79.4M

58.66%-23.4M

-33,700.00%-101.4M

36.87%204.9M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020	(FY)Jun 30, 2019	(FY)Dec 31, 2017	(Q4)Dec 31, 2017	(Q3)Sep 30, 2017	(Q2)Jun 30, 2017	(Q1)Mar 31, 2017
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	5.77%-4.96M	-586.43%-5.27M	-5.61%-767.31K	-85.83%-726.57K	-390.99K
Net income from continuing operations	20.18%-6.06M	-463.92%-7.59M	-65.78%-1.35M	-107.77%-812.37K	---390.99K	-34.13%112.3M	-46.38%28.9M	-73.05%11.4M	-29.76%23.6M	18.92%48.4M
Operating gains losses	--1.42K	----	----	----	----	66.32%-6.4M	75.00%-1.1M	-100.00%-16.8M	69.00%-3.1M	284.21%14.6M
Depreciation and amortization	27.35%769.69K	2,184.54%604.4K	178.02%26.46K	--9.52K	--0	8.24%249.7M	6.54%63.5M	6.67%62.4M	10.54%62.9M	9.34%60.9M
Deferred tax	----	----	----	----	----	-125.00%-600K	-98.11%100K	311.76%7M	-700.00%-3.2M	-7.14%-4.5M
Other non cash items	-695.68%-85.4K	---10.73K	----	----	----	4.38%14.3M	5.88%3.6M	2.70%3.8M	0.00%3.5M	9.68%3.4M
Change In working capital	50.30%-508.95K	-285.19%-1.02M	624.91%552.98K	--76.28K	--0	31.16%-46.4M	85.23%32.6M	67.67%-32.3M	-220.35%-148M	65.79%101.3M
-Change in receivables	----	----	----	----	----	---27.7M	---111.3M	107.55%22M	-341.86%-38M	-9.29%99.6M
-Change in inventory	----	----	----	----	----	-186.67%-1.3M	325.00%900K	-70.00%600K	-300.00%-400K	-700.00%-2.4M
-Change in prepaid assets	77.88%-23.15K	-1,237.23%-104.63K	58.20%-7.82K	---18.72K	--0	-44.00%-3.6M	-28.33%4.3M	4,300.00%4.2M	-252.38%-7.4M	25.40%-4.7M
-Change in payables and accrued expense	100.38%1.87K	-187.20%-489.03K	490.32%560.8K	--95K	--0	115.65%6.7M	16.45%106.2M	70.31%-21.2M	-2,203.03%-76M	96.12%-2.3M
-Change in other current liabilities	-13.30%-487.67K	---430.42K	--0	--0	----	----	----	----	----	----
-Change in other working capital	----	----	----	----	----	13.14%-20.5M	-0.31%32.5M	7.56%-37.9M	19.14%-26.2M	-35.47%11.1M
Cash from discontinued investing activities
Operating cash flow	5.77%-4.96M	-586.43%-5.27M	-5.61%-767.31K	-85.83%-726.57K	---390.99K	-0.15%409.9M	-5.10%154.3M	425.27%47.8M	-172.07%-41.8M	38.05%249.6M
Investing cash flow
Cash flow from continuing investing activities	100.55%58.98K	-10.78M	0	-117.84K	0
Capital expenditure reported	----	----	----	----	----	-16.52%-250.4M	-25.25%-74.9M	-8.37%-71.2M	-2.23%-59.6M	-43.73%-44.7M
Net PPE purchase and sale	96.62%-26.42K	---780.88K	--0	---117.84K	--0	----	----	----	----	----
Net business purchase and sale	----	----	----	----	----	-1,164.23%-173.2M	290.00%9.5M	90.00%-400K	-4,415.00%-180.6M	-142.86%-1.7M
Net investment purchase and sale	100.85%85.4K	---10M	--0	--0	----	----	----	--10.3M	--0	--0
Net other investing changes	----	----	----	----	----	828.57%13M	-7,400.00%-7.3M	--8.5M	--0	15.38%1.5M
Cash from discontinued investing activities
Investing cash flow	100.55%58.98K	---10.78M	--0	---117.84K	--0	-83.63%-410.6M	-12.36%-72.7M	24.25%-52.8M	-285.55%-240.2M	-66.91%-44.9M
Financing cash flow
Cash flow from continuing financing activities	-99.40%134.91K	4,995.12%22.41M	-55.50%439.75K	105.43%988.08K	480.99K
Net issuance payments of debt	--0	-170.58%-431.97K	-38.06%612.06K	105.43%988.08K	--480.99K	682.95%126.5M	-65.96%-7.8M	8.57%-6.4M	4,829.03%146.6M	14.49%-5.9M
Net common stock issuance	--0	--22.67M	--0	--0	----	----	----	----	----	----
Cash dividends paid	----	----	----	----	----	0.00%-138.9M	0.00%-34.5M	-0.29%-34.6M	0.00%-34.5M	0.28%-35.3M
Net other financing activities	-17.74%134.91K	195.18%164K	---172.31K	----	----	-866.67%-4.6M	--0	--0	-270.00%-3.4M	62.50%-1.2M
Cash from discontinued financing activities
Financing cash flow	-99.40%134.91K	4,995.12%22.41M	-55.50%439.75K	105.43%988.08K	--480.99K	89.38%-17M	-10.44%-42.3M	-0.99%-41M	405.34%108.7M	6.81%-42.4M
Net cash flow
Beginning cash position	10,700.66%6.42M	-84.65%59.41K	59.05%386.98K	58.71%243.31K	--153.3K	12.25%246.5M	1.39%189.5M	-18.26%235.5M	24.63%408.8M	12.25%246.5M
Current changes in cash	-175.01%-4.77M	2,040.86%6.36M	-328.00%-327.57K	59.63%143.67K	--90K	-165.80%-17.7M	-34.06%39.3M	54.55%-46M	-334.34%-173.3M	49.72%162.3M
Effect of exchange rate changes	---83.15K	--0	--0	----	----	----	----	----	----	----
End cash Position	-75.61%1.56M	10,700.66%6.42M	-84.65%59.41K	59.05%386.98K	--243.31K	-7.18%228.8M	-7.18%228.8M	1.39%189.5M	-18.26%235.5M	24.63%408.8M
Free cash flow	17.49%-4.99M	-688.20%-6.05M	9.13%-767.31K	-115.97%-844.41K	---390.99K	-18.46%159.5M	-22.76%79.4M	58.66%-23.4M	-33,700.00%-101.4M	36.87%204.9M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall